Correlation Between Phibro Animal and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Phibro Animal and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phibro Animal and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phibro Animal Health and Neurocrine Biosciences, you can compare the effects of market volatilities on Phibro Animal and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phibro Animal with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phibro Animal and Neurocrine Biosciences.
Diversification Opportunities for Phibro Animal and Neurocrine Biosciences
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Phibro and Neurocrine is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Phibro Animal Health and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Phibro Animal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phibro Animal Health are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Phibro Animal i.e., Phibro Animal and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Phibro Animal and Neurocrine Biosciences
Given the investment horizon of 90 days Phibro Animal Health is expected to generate 0.97 times more return on investment than Neurocrine Biosciences. However, Phibro Animal Health is 1.03 times less risky than Neurocrine Biosciences. It trades about 0.01 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.25 per unit of risk. If you would invest 2,229 in Phibro Animal Health on November 28, 2024 and sell it today you would lose (17.00) from holding Phibro Animal Health or give up 0.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phibro Animal Health vs. Neurocrine Biosciences
Performance |
| Timeline |
| Phibro Animal Health |
| Neurocrine Biosciences |
Phibro Animal and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phibro Animal and Neurocrine Biosciences
The main advantage of trading using opposite Phibro Animal and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phibro Animal position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Phibro Animal vs. Pacira BioSciences, | Phibro Animal vs. Dr Reddys Laboratories | Phibro Animal vs. Collegium Pharmaceutical | Phibro Animal vs. ANI Pharmaceuticals |
| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |